Dental practices don't sell for a single multiple. A solo general practice and a multi-doctor specialty group can have the same EBITDA and trade at prices 3x apart. The difference isn't the revenue number. It's who the buyer is, what the payer mix looks like, whether the practice can operate without the selling dentist in the chair, and whether DSO acquisition programs will touch it at all. This page breaks down the ranges by practice type and explains what actually moves the number.
Ranges below reflect indicative lower-middle-market dental transaction patterns compiled from IBBA Market Pulse quarterly surveys, ADA Health Policy Institute economic data, published benchmarks from dental-specialist transaction advisors, and BizBuySell healthcare transaction reporting for 2024–2026. They are not a formal valuation. Your actual outcome depends on practice-specific earnings quality, payer mix, deal structure, and the buyer process you run. For the broader healthcare sector benchmark, see the EBITDA and SDE multiples by industry report, which places Healthcare & Medical Practices at 6–10x EBITDA overall.
Valuation Multiples by Dental Practice Type
The table covers the four main dental practice categories that appear in lower-middle-market M&A. Collections multiples apply to solo practices selling to individual dentist buyers; EBITDA multiples apply to practices with a paid clinical team where DSO and institutional buyers are relevant.
| Practice Type | EBITDA Multiple | Collections / SDE Multiple | Typical Deal Size | Sale Timeline | Primary Buyers |
|---|---|---|---|---|---|
| Solo General Practice (owner-operator) | 2.5–3.5x SDE | 0.5–0.8x collections | $300K–$2M | 6–9 months | Individual DentistsSBA Buyers |
| Multi-Doctor General Practice | 3.5–5.5x | 0.7–1.0x collections | $1M–$8M | 7–12 months | DSOsHealthcare PERegional Groups |
| Specialty Practice (ortho, OS, perio, endo) | 5–8x | N/A (EBITDA basis) | $2M–$20M | 8–14 months | Specialty DSOsHealthcare PE |
| DSO-Ready Group / Platform ($1M+ EBITDA) | 5–8x+ | N/A (EBITDA basis) | $5M–$30M+ | 9–15 months | National DSOsHealthcare PE |
Ranges reflect indicative lower-middle-market transaction patterns, not a formal valuation. Specialty practices with dominant referral networks, strong fee-for-service payer mix, and multiple competing DSO platforms can exceed the 8x upper bound shown. For a quick indicative value based on your own earnings, use the ProCloser business valuation calculator.
Practice Type Deep Dive
Solo General Practice (Owner-Operator)
Solo owner-operator practices are the most common dental transactions by volume and the most consistently priced on a collections multiple basis rather than EBITDA. Individual dentist buyers think in terms of what percentage of annual production they're willing to pay, and SBA lenders use the same framework when underwriting the acquisition loan. A practice collecting $800K annually in a decent location with reasonable payer mix and a stable patient base typically trades in the $480K–$640K range under a 0.6–0.8x collections multiple.
The multiple within this range pivots on two things: payer mix and owner dependence. A practice running 50%+ fee-for-service and PPO revenue with a documented recall schedule for 800+ active patients lands toward 0.8x. One running 40% Medicaid, where the selling dentist personally handles most of the production, is a materially different asset for a buyer to underwrite, and the price reflects that. DSOs generally pass on practices at this tier unless the location and patient panel offer a quick add-on to an existing platform location. The buyer market here is almost entirely individual dentists financing through SBA 7(a) loans, which adds 60–90 days to the deal timeline due to lender requirements.
Multi-Doctor General Practice
Once a general practice has one or more associate dentists generating meaningful production alongside the owner, the applicable valuation framework shifts from collections multiples to EBITDA, and the buyer pool expands from individual dentists to include DSOs, regional group practices, and healthcare private equity platforms. The associate revenue is the key: a buyer paying 4x EBITDA is acquiring a business that continues producing after the selling dentist transitions, not just buying a patient list tied to one person.
The multiple spread from 3.5x to 5.5x EBITDA in this category is almost entirely driven by payer mix and the depth of the non-owner clinical team. A multi-doctor practice with 60%+ fee-for-service revenue, two producing associates each generating $600K+ annually, and a strong hygiene recall rate above 65% of active patients is the practice DSO platforms acquire. A same-size practice with a 50% Medicaid patient base, one part-time associate, and declining hygiene utilization sits at the low end or may not attract DSO interest at all. The 2-turn spread on the same EBITDA number isn't abstract; it reflects buyers' direct assessment of how defensible the cash flow is after the owner's employment period ends.
Specialty Practice (Orthodontics, Oral Surgery, Periodontics, Endodontics)
Specialty dental practices command the highest multiples in dental M&A and it comes down to two structural advantages that general practices don't have. Their referral networks are built around relationships with other dentists rather than with patients directly, which means the revenue isn't tied to any individual patient's loyalty. And specialty care is predominantly fee-for-service or out-of-network, which gives buyers clean, high-margin revenue without the Medicaid and HMO reimbursement compression that discounts general practice valuations.
Orthodontics has been particularly active from a PE and DSO acquisition standpoint, with multiple specialty platforms competing for quality practices across most metro markets. An orthodontic practice with $800K in EBITDA, a strong referral network of 15+ referring GPs, and a demonstrated ability to maintain case starts without the selling orthodontist's personal relationships will see meaningful buyer competition. Oral surgery follows closely, driven by the same fee-for-service revenue profile and the complexity of the clinical work creating higher barriers to competitive entry than general dentistry. Periodontics and endodontics earn similar multiples, though their transaction volumes are lower. For all specialty types, the referral network's transferability is the key diligence question buyers probe first.
DSO-Ready Group or Platform Practice
Multi-location groups and platform-scale practices that have built a real management infrastructure operate in a different buyer tier. National DSO platforms and healthcare PE firms acquiring founder-owned dental groups at this scale are buying a business they can integrate into an existing platform or use as a foundation for regional expansion, not just a clinical practice. They run structured acquisition programs, have deal teams that have closed dozens of transactions, and move with a predictability that makes the process more efficient than solo-practice transactions.
What separates an 8x+ outcome from a 5x outcome at this tier isn't EBITDA size alone; it's the quality of the infrastructure. A group with centralized scheduling, standardized treatment protocols, a documented training program for associates, and management reporting that doesn't require the founder to be physically present to run is worth significantly more than a same-revenue group where the owner is still making operational decisions across every location. PE and DSO buyers at this tier often offer rollover equity structures alongside the upfront cash payment, which means sellers have a path to a second liquidity event when the platform sells. The rollover percentage and structure is worth negotiating carefully, as it can represent 10–30% of total proceeds in a successful outcome.
What Moves a Dental Practice Multiple
Two dental practices with the same EBITDA can sell at prices 40–50% apart. These are the factors that consistently drive that gap.
- Payer mix. This is the single most impactful variable in dental M&A, and by a wide margin. Fee-for-service and out-of-network collections are valued higher than equivalent PPO, HMO, or Medicaid revenue because they carry better margins, signal patient loyalty to the practice rather than to the insurance plan, and attract the institutional buyer pool. A practice running 60% or more in FFS revenue commands meaningfully higher multiples than an identically sized practice running primarily on Medicaid. The gap can be several full multiple turns on the same EBITDA. DSO platforms often exclude Medicaid-heavy practices from their acquisition criteria entirely, which dramatically limits the buyer pool and compresses the ultimate price.
- Owner-producer dependence. If the selling dentist is the primary clinical producer and patients come specifically to see them, a buyer is acquiring revenue that may not survive the transition period. Adding associate dentist production that's not tied to the owner's personal patient relationships is the most reliable way to expand the applicable buyer pool and the multiple range. Even one associate generating $500K+ annually changes the acquisition math for DSO buyers in a material way.
- Hygiene program quality. Hygiene production represents recurring revenue from an existing patient base, and buyers treat it as a signal of patient panel health. Hygiene utilization rate (hygiene production as a percentage of total practice production) above 25–30% for a general practice indicates an active recall base. Practices with weak hygiene programs have a patient retention problem that buyers will price in, because the patient base they're acquiring isn't coming back reliably without the recall mechanism to bring them in.
- Lease terms. Most dental practices operate in leased space, and a short remaining lease with no renewal right creates near-term real estate risk. Buyers will require a lease with at least 5–7 years of remaining term, or a favorable renewal option, before closing. A lease with fewer than 3 years remaining and no renewal right is a deal complication that advisors flag on the first review. Negotiating a lease extension before going to market, if the current term is short, often pays back in deal certainty rather than just price.
- Equipment condition and technology. Digital X-ray systems, a cone beam CT scanner, modern sterilization equipment, and chairside CAD/CAM all signal a practice that isn't carrying a near-term capital expenditure burden. Buyers commission equipment appraisals on every meaningful transaction. An aging equipment base that requires $150K in replacement within the first year after close becomes a negotiating point that erodes the effective purchase price. Refreshing equipment 12–18 months before a planned sale typically pays back in deal pricing.
- HIPAA compliance and clinical records. Deficiencies in patient record documentation, HIPAA compliance policies, or controlled substance handling surface in diligence and become either price adjustments or deal complications. DSO platforms run structured diligence that covers clinical compliance areas general business buyers typically skip. Addressing compliance gaps before going to market is cheaper than negotiating around them after a buyer finds them.
The single highest-leverage preparation step for most general practices is adding associate dentist production before going to market. Practices where the owner is the sole producer are functionally limited to the individual dentist buyer market, which tops out at 0.8x collections. The same practice with one producing associate generating $600K+ annually becomes DSO-eligible, which opens the 3.5–5.5x EBITDA range and the institutional buyer competition that drives prices to the top of it. The 18–24 month runway for associate recruitment and integration makes this worth starting early.
Who Buys Dental Practices in 2026
Buyer type determines the multiple ceiling, the deal structure, and the post-close expectations. Dental M&A has two nearly non-overlapping buyer markets that coexist, divided roughly at $2M enterprise value.
- Dental Support Organizations (DSOs) are the most active and highest-paying buyers for practices with $300K or more in EBITDA. National DSOs like Heartland Dental, Aspen Dental, Pacific Dental Services, and dozens of regional and specialty platforms run structured acquisition programs that have collectively executed thousands of transactions. They understand diligence quickly, have integration playbooks that minimize disruption to the practice, and consistently pay the highest multiples in their target size range. The trade-off: they require the selling dentist to stay on under an employment arrangement for 1–3 years post-close, and the deal structure involves a professional corporation restructuring to comply with state corporate practice of dentistry laws. DSO rollover equity, which ranges from 10–30% of the transaction, is worth evaluating against the DSO's growth trajectory and exit timeline.
- Healthcare private equity platforms build dental groups through acquisitions rather than operating practices directly. They compete with DSOs for quality multi-doctor and specialty practices, bring structured capital, and create the buyer competition that pushes multiples to the 6–8x EBITDA range. PE-backed deals run more formal processes with quality of earnings engagements and legal diligence that individual-buyer transactions skip. They typically seek practices with $500K or more in EBITDA, a management layer that can operate without the founder, and a demonstrable path to add-on acquisitions.
- Regional dental groups are growing practices or small DSOs buying for geographic expansion, specialty capacity, or patient base consolidation. Their processes are less formal than large DSOs and typically move faster. They pay competitive multiples in their target markets, though their ceiling is generally below national DSOs and PE platforms with more capital at their disposal.
- Individual dentists using SBA financing dominate the sub-$2M enterprise value market. They buy primarily based on collections multiples, move slower than institutional buyers due to SBA lender timelines, and typically offer cleaner post-close exits for sellers who want to step away fully without an extended employment obligation. SBA-financed transactions add 60–90 days to deal timelines due to lender appraisal and underwriting requirements. Most SBA lenders require the selling dentist to provide some form of seller note, typically 10–20% of the purchase price, subordinated to the SBA loan.
For a benchmark of what dental and healthcare deals in your revenue range are closing at, the ProCloser deal valuation benchmarks index transaction patterns by deal size and sector. The full process walkthrough, including how DSO corporate structures work, payer credentialing planning, and DEA registration transition, is in the guide to selling a dental practice.
Why Dental Practice Sales Take 6 to 15 Months
Dental transactions take longer than most service business sales because of three regulatory and operational steps that don't exist in other sectors.
- Payer credentialing. When a dental practice changes hands, the new provider must apply for their own credentialing status with each insurance carrier. Most carriers take 30–90 days per payer, and a practice with 10 active payer relationships faces a credentialing queue spanning months if not started early enough. Some carriers allow provisional billing arrangements during the credentialing gap; others don't. A collections disruption caused by a credentialing gap at the wrong moment, just after close when the new owner is adjusting, can materially affect the transition. Experienced dental M&A advisors build credentialing timelines into the deal structure from the start.
- DEA registration transition. Practices that dispense or store controlled substances under a DEA registration cannot transfer the seller's DEA number to the buyer. The incoming dentist must apply for their own registration at the practice address, which takes 4–12 weeks and requires an active state license at that location. Practices offering IV sedation need DEA transition planning built into the deal structure before closing, not after.
- Corporate practice of dentistry compliance. In most states, a non-dentist entity cannot directly own a dental practice. DSO transactions work around this through a Management Services Agreement structure where the DSO acquires the non-clinical management assets while the dentist retains a professional entity holding the clinical license. Setting up this structure correctly takes time, requires specialized dental M&A legal counsel, and is one of the primary reasons DSO transactions take longer than individual dentist purchases of similar-sized practices.
Sellers who prepare 3 years of clean practice financials, payer-by-payer production reports, an active patient count analysis, and a confirmed lease review before engaging an advisor consistently close faster than those who assemble these during the transaction. For a sector-by-sector comparison of how dental timelines compare to other business types, see the average time to sell a business by industry.
Frequently Asked Questions
What are typical dental practice valuation multiples?
Dental practice valuation multiples vary by practice type and buyer. Solo general practices selling to individual dentist buyers trade at 0.5–0.8x gross annual collections, equivalent to roughly 2.5–3.5x SDE. Multi-doctor general practices with associate depth and DSO-eligible payer mix sell for 3.5–5.5x EBITDA. Specialty practices (orthodontics, oral surgery, periodontics, endodontics) and DSO-ready platforms with $500K or more in EBITDA command 5–8x EBITDA when run through a competitive process. Payer mix is the single biggest within-range driver: practices with 60% or more fee-for-service revenue earn materially higher multiples than insurance-heavy peers with identical earnings.
How much is a solo dental practice worth?
A solo general dentistry practice is typically worth 0.5–0.8x gross annual collections when selling to an individual dentist buyer. A practice collecting $1M annually would carry an indicative range of $500K–$800K under this framework, equivalent to roughly 2.5–3.5x seller's discretionary earnings. The primary discount factors are owner-producer dependence (all revenue tied to the selling dentist personally), a Medicaid or HMO-heavy payer mix, and a short remaining lease. Practices with 60%+ fee-for-service revenue and a stable hygiene recall program land at the top end.
What multiple does a dental practice sell for to a DSO?
Dental practices that qualify as DSO acquisition targets typically sell for 5–8x EBITDA, with the range driven by practice size, payer mix quality, and buyer competition. A multi-doctor practice with $500K or more in EBITDA, 50%+ fee-for-service revenue, and associate production that doesn't depend on the seller as the sole producer is the core DSO acquisition profile. Specialty practices can exceed 8x when multiple DSO and PE platforms compete in a well-run process. The gap between a 5x and 8x outcome on the same EBITDA comes from payer mix quality, the depth of the non-owner clinical team, and how the process is run.
Does payer mix affect dental practice valuation?
Yes, significantly. Payer mix is the single most impactful factor in dental practice valuation. Fee-for-service and out-of-network revenue earns higher multiples than equivalent PPO, HMO, or Medicaid revenue, because it carries better margins and signals patient loyalty to the practice rather than to the insurance plan. A practice running 60% or more in FFS collections can be worth several full multiple turns more than an identically sized Medicaid-heavy practice. DSO platforms exclude Medicaid-heavy practices from their acquisition programs entirely in many cases, which limits the buyer pool to individual dentists and compresses the price accordingly.
What hurts dental practice valuation the most?
The biggest valuation discounts come from: a high proportion of Medicaid or HMO revenue that limits DSO buyer eligibility; owner-producer dependence where the selling dentist is the only clinical producer; aging equipment requiring near-term capital expenditure; a short remaining lease with no renewal option; poor hygiene program utilization; HIPAA compliance gaps; and patient concentration tied to referral relationships the seller personally controls. Most of these are addressable with 12–24 months of deliberate preparation. Adding an associate dentist, restructuring payer mix toward fee-for-service, and negotiating a lease extension are the three highest-leverage steps for most general practices.
What specialty dental practices sell for the highest multiples?
Orthodontic practices consistently earn the highest multiples in dental M&A, typically 6–9x EBITDA in competitive processes, because they have the strongest recurring revenue profile (multi-year patient treatment plans with predictable case completion), the most active DSO roll-up demand, and a default fee-for-service revenue model. Oral surgery practices follow at 5–8x EBITDA. Periodontics and endodontics earn similar multiples. The common thread across all high-multiple specialty practices is a referral network built independently of the selling practitioner's personal relationships, and a case mix that doesn't depend on Medicaid funding.
How long does it take to sell a dental practice?
Individual dentist buyer transactions typically close in 6–9 months. DSO and PE-level transactions typically run 9–15 months. Payer credentialing is the primary variable that extends dental deal timelines: each insurance carrier takes 30–90 days to credential a new provider, and most practices carry 5–15 active payer relationships. DEA registration transition for practices with controlled substances adds 4–12 weeks. DSO transactions also require professional corporation restructuring for corporate practice of dentistry compliance. Sellers who start credentialing prep, lease review, and DEA planning 12–18 months before a planned sale shorten the active transaction period meaningfully.
Who are the most active buyers of dental practices in 2026?
DSOs are the most active and highest-paying buyers for practices with $300K or more in EBITDA. Healthcare PE platforms building dental roll-ups compete with DSOs for quality multi-doctor and specialty practices and create the buyer competition that pushes multiples to the top of the range. Individual dentists using SBA financing dominate the sub-$2M enterprise value market. Regional dental groups are active in mid-sized markets, buying for geographic expansion and specialty capacity. The DSO market has continued to consolidate in 2026, with larger national platforms acquiring smaller regional DSOs and their underlying practices, which keeps acquisition demand elevated for quality practices.